Yiyi Xi

999 total citations
9 papers, 315 citations indexed

About

Yiyi Xi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yiyi Xi has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Yiyi Xi's work include Cancer Genomics and Diagnostics (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Yiyi Xi is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Yiyi Xi collaborates with scholars based in China, United States and United Kingdom. Yiyi Xi's co-authors include Dongxin Lin, Chen Wu, Wenyi Fan, Yuling Ma, Yamei Chen, Tianyuan Liu, Wen Tan, Yingying Luo, Shaosen Zhang and Xuan Zhao and has published in prestigious journals such as Nature Communications, Cancer Cell and Cancer Research.

In The Last Decade

Yiyi Xi

9 papers receiving 315 citations

Peers

Yiyi Xi

MB

ONCOL

CR

SURGE

IMMUN

Wenyi Fan United States

Tianyuan Liu China

Stefania Belli Italy

Areum Jo South Korea

Shingo Togano Japan

Daniela I. Paiva‐Oliveira Portugal

Daiki Eguchi Japan

Yasuyuki Okada Japan

Silvia Schmidtova Slovakia

Jian-Ping Huo China

Wenyi Fan United States

Yiyi Xi

180 ×1.0

MB

163 ×1.2

ONCOL

87 ×0.9

CR

83 ×1.0

SURGE

70 ×0.9

IMMUN

Citations per year, relative to Yiyi Xi Yiyi Xi (= 1×) peers Wenyi Fan

Countries citing papers authored by Yiyi Xi

Since Specialization

Citations

This map shows the geographic impact of Yiyi Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiyi Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiyi Xi more than expected).

Fields of papers citing papers by Yiyi Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiyi Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiyi Xi. The network helps show where Yiyi Xi may publish in the future.

Co-authorship network of co-authors of Yiyi Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Yiyi Xi. A scholar is included among the top collaborators of Yiyi Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiyi Xi. Yiyi Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chen, Xinjie, Shaosen Zhang, Wenyi Fan, et al.. (2023). Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer. Cell Reports. 42(10). 113270–113270. 23 indexed citations

2.

Chen, Yamei, Shihao Zhu, Tianyuan Liu, et al.. (2023). Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell. 41(5). 903–918.e8. 88 indexed citations

3.

Liu, Tianyuan, Xuan Zhao, Yuan Lin, et al.. (2022). Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression. Cancer Research. 82(14). 2520–2537. 16 indexed citations

4.

Wang, Yuqian, Jie Yang, Tianyuan Liu, et al.. (2022). Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in Oncology. 12. 4 indexed citations

5.

Liu, Weiling, Chuanwang Miao, Shaosen Zhang, et al.. (2021). VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduction and Targeted Therapy. 6(1). 322–322. 26 indexed citations

6.

Chu, Jiahui, Xiangjie Niu, Jiang Chang, et al.. (2020). Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma. Theranostics. 10(8). 3488–3502. 27 indexed citations

7.

Yao, Jiacheng, Qionghua Cui, Wenyi Fan, et al.. (2020). Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer. Nature Communications. 11(1). 3715–3715. 88 indexed citations

8.

Lin, Yuan, Yingying Luo, Yanxia Sun, et al.. (2020). Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction. Nature Communications. 11(1). 6091–6091. 29 indexed citations

9.

Peng, Linna, Sijin Cheng, Yuan Lin, et al.. (2018). CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population. Genomics Proteomics & Bioinformatics. 16(4). 262–268. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact